New York TimesLean L·
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read at New York Times →
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

<iframe src="https://statesidedaily.com/embed/cluster/d6608969bdf0f7fd311c31f544a89703be71b9e4" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="F.D.A. Rejects Closely Watched Lung Cancer Drug From China"></iframe>
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
